Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 410 publications
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.
Journal: JCO oncology advances
Published: September 01, 2026
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.
Journal: Nature
Published: August 05, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.
Journal: Cancer research communications
Published: July 20, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
Journal: The New England journal of medicine
Published: July 01, 2026
Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer.
Journal: JAMA network open
Published: June 24, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 22, 2026
Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).
Journal: JCO oncology advances
Published: June 03, 2026
Redefining therapy for previously treated renal cell carcinoma.
Journal: Lancet (London, England)
Published: June 03, 2026
Precision Intensification in Metastatic Prostate Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study.
Journal: JCO global oncology
Published: May 29, 2026
Last Updated: 09/26/2026